+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats



Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats



Antimicrobial Agents and ChemoTherapy 31(11): 1809-1815



The antibacterial activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in vivo were compared. Although there was only a minor difference between the MBCs of both drugs, the bacterial killing rate of ciprofloxacin in vitro was very fast in comparison with that of ceftazidime. Similarly, the intravenous administration of ciprofloxacin at 1 h after bacterial inoculation resulted in effective bacterial killing in the lungs of leukopenic rats. This killing was dose dependent, in contrast to the dose-independent bactericidal effect of ceftazidime. The high antibacterial activity of ciprofloxacin in the lungs as compared with that of ceftazidime was also reflected in its therapeutic efficacy in K. pneumoniae pneumonia and septicemia in leukopenic rats when these infections were treated at 6-h intervals over 4 days, starting at 5 h after bacterial inoculation. Concentrations of ciprofloxacin and ceftazidime in lung tissue were not significantly different. Regarding the antibacterial activity of both drugs against K. pneumoniae in relation to the bacterial growth rate in vitro and in the lungs of leukopenic rats, ciprofloxacin killed K. pneumoniae organisms that were not actively growing, whereas ceftazidime did not. In addition, it was demonstrated that when the intravenous administration of antibiotic was delayed from 1 h up to 24 h after bacterial inoculation, ceftazidime lost its antibacterial activity in the lungs and blood of leukopenic rats, whereas ciprofloxacin was still very effective. These data suggest that the capacity of an antibiotic to kill bacteria at a slow growth rate may be relevant for its therapeutic effect in established infections, in which slowly growing bacteria form a substantial part of the total bacterial population.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614432

Download citation: RISBibTeXText

PMID: 3324962

DOI: 10.1128/aac.31.11.1809


Related references

Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. European Journal of Clinical Microbiology & Infectious Diseases 10(12): 1019-1025, 1991

Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. European Journal of Clinical Microbiology and Infectious Diseases 8(10): 878-887, 1989

Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro. Pharmaceutisch Weekblad. Scientific Edition 9 Suppl: S33-S40, 1987

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrobial Agents and ChemoTherapy 30(3): 403-408, 1986

Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice. Infection 16(1): 49-53, 1988

Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrobial Agents and ChemoTherapy 22(6): 1042-1050, 1982

Therapeutic effects of ceftazidime cefotaxime and cefazolin on experimental pneumonia caused by klebsiella pneumoniae in rats. Abstracts of the Annual Meeting of the American Society for Microbiology 82: ABSTRACT A59, 1982

Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. Journal of Infectious Diseases 152(2): 373-378, 1985

The experimental study on the therapeutic efficacy of two kinds of intraperitoneal administration of ceftazidime in the Klebsiella pneumoniae pneumonia in the rats. Zhongguo Kangshengsu Zazhi 27(1): 42-45, 2002

Efficacy of liposomal gentamicin against Klebsiella pneumoniae pneumonia in rats with intact host defense and leukopenic rats. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 56, 1999

The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats. Antimicrobial Agents and ChemoTherapy 57(1): 643-646, 2013

The Therapeutic Effect of Tigecycline, Unlike That of Ceftazidime, Is Not Influenced by whether the Klebsiella pneumoniae Strain Produces Extended-Spectrum beta-Lactamases in Experimental Pneumonia in Rats. 2013

Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrobial Agents and ChemoTherapy 43(8): 2051-2055, 1999

Efficacy of liposome-encapsulated ciprofloxacin in Klebsiella pneumoniae pneumonia in rats. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 55, 1998

Relevance of in vitro antibacterial activities of cefotiam and cefazolin to their therapeutic effects on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice. Journal of Antibiotics 34(2): 231-239, 1981